Nextage Therapeutics (XTAE:NXTG) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:NXTG Nextage Therapeutics Ltd XTAE:NXTG
12 GF Score
Price ₪0.44
GF Value ₪0.24
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Nextage Therapeutics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XTAE:NXTG
12GF Score
Nextage Therapeutics Ltd XTAE:NXTG
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nextage Therapeutics (XTAE:NXTG) Overvalued in 2026?

Based on GuruFocus' analysis, Nextage Therapeutics stock appears to be overvalued. The current stock price of ₪0.44 is trading 83.3% above its estimated GF Value™ of ₪0.24. GuruFocus considers Nextage Therapeutics to be Significantly Overvalued.

Key valuation signals for XTAE:NXTG:

  • Dividends Received:
  • GF Value™: ₪0.24 vs. price of ₪0.44 (83.3% above fair value)
  • GF Score™: 12/100 with 4 warning signs

No single metric tells the full story. See the XTAE:NXTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nextage Therapeutics Business Description

Address Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.
12GF Score

Get the complete analysis for XTAE:NXTG

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.44
Price
₪0.24
GF Value